UCB S.A. - Company Profile and SWOT Analysis
Summary
UCB S.A. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
UCB S.A. (UCB or 'the company') is a global biopharmaceutical company. It focuses on the discovery and development of medicines for people living with severe diseases in two therapeutic areas, immunology and neurology. UCB also offers a range of products for the treatment of patients with epilepsy, Parkinson's disease, restless legs syndrome, axial spondyloarthritis, Crohn's disease, psoriatic arthritis, rheumotoid arthritis, Osteoporo, Lupus, and Psoriasis, among others. The company's major brands include Cimzia, Vimpat, Keppra, Briviact, Neupro, Nayzilam, Evenity, Cirrus and Xyzal. The company operates across Europe, North America, and Asia-Pacific. The company is headquartered in Brussels, Belgium.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook